Looks like you clickedhttp://www.prnewswire.com/news-releases/abbvie-announces-fourth-breakthrough-therapy-designation-granted-by-the-us-food-and-drug-administration-fda-for-ibrutinib-imbruvica-for-chronic-graft-versus-host-disease-cgvhd-a-rare-condition-with-limited-treatment-opti-300291656.html
If you do not want to visit that page, you can close this browser tab.
